rtki cpd and Nasopharyngeal Neoplasms

rtki cpd has been researched along with Nasopharyngeal Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feng, GK; Li, ZM; Liu, ZC; Xie, BF; Yang, D; Zeng, YX; Zhu, XF1

Other Studies

1 other study(ies) available for rtki cpd and Nasopharyngeal Neoplasms

ArticleYear
EGFR tyrosine kinase inhibitor AG1478 inhibits cell proliferation and arrests cell cycle in nasopharyngeal carcinoma cells.
    Cancer letters, 2001, Aug-10, Volume: 169, Issue:1

    Topics: Cell Cycle; Cell Cycle Proteins; Cell Division; Cyclin-Dependent Kinase Inhibitor p27; Enzyme Activation; Enzyme Inhibitors; ErbB Receptors; G1 Phase; Growth Inhibitors; Humans; MAP Kinase Signaling System; Microtubule-Associated Proteins; Mitogen-Activated Protein Kinases; Nasopharyngeal Neoplasms; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Quinazolines; Tumor Cells, Cultured; Tumor Suppressor Proteins; Tyrphostins; Up-Regulation

2001